# Centre Hospitalier de Bethune: Phase 2 study terminated, 65 enrolled (Cardiac Arrest)

**Score:** 65/100

| Field | Value |
|---|---|
| Sponsor | Centre Hospitalier de Bethune |
| Sponsor type | Research network |
| Study | Efficacy of Early Intravenous High-dose Vitamin C in Post-cardiac Arrest Shock. |
| NCT ID | NCT05817851 |
| Phase | Phase 2 |
| Status | terminated |
| Conditions | Cardiac Arrest |
| Intervention types | drug |
| Target enrollment | 65 |
| Site countries | France |
| Posted | 2023-04-18 |
| Planned start | 2023-12-27 |
| Event | Terminated |
| Event date | 2026-09-30 |
| Last update posted | 2026-10-27 |

## Why this score
- Posted in the last two weeks.
- Stopped early: budget and sites freed up.
- Phase 2: multi-site, larger budget.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT05817851). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.